Altamira Therapeutics Stock Technical Analysis

CYTO Stock  USD 0.40  0.02  4.17%   
As of the 28th of November, Altamira Therapeutics shows the Standard Deviation of 4.68, mean deviation of 3.49, and Risk Adjusted Performance of (0.16). Altamira Therapeutics technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices.

Altamira Therapeutics Momentum Analysis

Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as Altamira, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to Altamira
  
Altamira Therapeutics' Momentum analyses are specifically helpful, as they help investors time the market using mark points where the market can reverse. The reversal spots are usually identified through divergence between price movement and momentum.
Altamira Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of Altamira Therapeutics technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Altamira Therapeutics trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Altamira Therapeutics Technical Analysis

Indicator
Time Period
Execute Indicator
The output start index for this execution was fourteen with a total number of output elements of fourty-seven. The Average True Range was developed by J. Welles Wilder in 1970s. It is one of components of the Welles Wilder Directional Movement indicators. The ATR is a measure of Altamira Therapeutics volatility. High ATR values indicate high volatility, and low values indicate low volatility.

Altamira Therapeutics Trend Analysis

Use this graph to draw trend lines for Altamira Therapeutics. You can use it to identify possible trend reversals for Altamira Therapeutics as well as other signals and approximate when it will take place. Remember, you need at least two touches of the trend line with actual Altamira Therapeutics price movement. To start drawing, click on the pencil icon on top-right. To remove the trend, use eraser icon.

Altamira Therapeutics Best Fit Change Line

The following chart estimates an ordinary least squares regression model for Altamira Therapeutics applied against its price change over selected period. The best fit line has a slop of   0.0078  , which may suggest that Altamira Therapeutics market price will keep on failing further. It has 122 observation points and a regression sum of squares at 2.31, which is the sum of squared deviations for the predicted Altamira Therapeutics price change compared to its average price change.

About Altamira Therapeutics Technical Analysis

The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of Altamira Therapeutics on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of Altamira Therapeutics based on its technical analysis. In general, a bottom-up approach, as applied to this company, focuses on Altamira Therapeutics price pattern first instead of the macroeconomic environment surrounding Altamira Therapeutics. By analyzing Altamira Therapeutics's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of Altamira Therapeutics's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to Altamira Therapeutics specific price patterns or momentum indicators. Please read more on our technical analysis page.
 2010 2022 2023 2024 (projected)
Payables Turnover0.630.30.350.52
Days Of Inventory On Hand136.712.943.393.22

Altamira Therapeutics November 28, 2024 Technical Indicators

Most technical analysis of Altamira help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Altamira from various momentum indicators to cycle indicators. When you analyze Altamira charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

Altamira Therapeutics November 28, 2024 Daily Trend Indicators

Traders often use several different daily volumes and price technical indicators to supplement a more traditional technical analysis when analyzing securities such as Altamira stock. With literally thousands of different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
When determining whether Altamira Therapeutics offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Altamira Therapeutics' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Altamira Therapeutics Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Altamira Therapeutics Stock:
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Altamira Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate.
To learn how to invest in Altamira Stock, please use our How to Invest in Altamira Therapeutics guide.
You can also try the Money Managers module to screen money managers from public funds and ETFs managed around the world.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Altamira Therapeutics. If investors know Altamira will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Altamira Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
1.82
Revenue Per Share
0.917
Quarterly Revenue Growth
(0.64)
Return On Assets
(0.57)
Return On Equity
(3.69)
The market value of Altamira Therapeutics is measured differently than its book value, which is the value of Altamira that is recorded on the company's balance sheet. Investors also form their own opinion of Altamira Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Altamira Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Altamira Therapeutics' market value can be influenced by many factors that don't directly affect Altamira Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Altamira Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Altamira Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Altamira Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.